Vivos, Inc. (RDGL)
0.0453
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Vivos Enterprise Value : 29.49M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 29.49M |
| October 05, 2026 | 28.42M |
| October 02, 2026 | 29.75M |
| October 01, 2026 | 31.73M |
| September 30, 2026 | 31.83M |
| September 29, 2026 | 31.04M |
| September 28, 2026 | 28.79M |
| September 25, 2026 | 29.81M |
| September 24, 2026 | 30.19M |
| September 23, 2026 | 29.85M |
| September 22, 2026 | 30.05M |
| September 21, 2026 | 29.90M |
| September 18, 2026 | 31.02M |
| September 17, 2026 | 31.14M |
| September 16, 2026 | 30.84M |
| September 15, 2026 | 31.14M |
| September 14, 2026 | 30.79M |
| September 11, 2026 | 31.63M |
| September 10, 2026 | 31.63M |
| September 09, 2026 | 31.01M |
| September 08, 2026 | 31.64M |
| September 04, 2026 | 32.03M |
| September 03, 2026 | 31.91M |
| September 02, 2026 | 33.85M |
| September 01, 2026 | 32.45M |
| Date | Value |
|---|---|
| August 31, 2026 | 32.42M |
| August 28, 2026 | 33.46M |
| August 27, 2026 | 32.29M |
| August 26, 2026 | 32.32M |
| August 25, 2026 | 33.16M |
| August 24, 2026 | 34.20M |
| August 21, 2026 | 33.36M |
| August 20, 2026 | 33.65M |
| August 19, 2026 | 35.19M |
| August 18, 2026 | 34.89M |
| August 17, 2026 | 35.46M |
| August 14, 2026 | 34.30M |
| August 13, 2026 | 33.93M |
| August 12, 2026 | 34.15M |
| August 11, 2026 | 33.01M |
| August 10, 2026 | 33.71M |
| August 07, 2026 | 32.67M |
| August 06, 2026 | 35.78M |
| August 05, 2026 | 36.18M |
| August 04, 2026 | 36.47M |
| August 03, 2026 | 38.10M |
| July 31, 2026 | 35.47M |
| July 30, 2026 | 36.46M |
| July 29, 2026 | 35.91M |
| July 28, 2026 | 35.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IDEXX Laboratories, Inc. | 41.55B |
| Neogen Corp. | 3.230B |
| QuidelOrtho Corp. | 3.811B |
| Aspira Women's Health, Inc. | 12.89M |
| Biomerica, Inc. | 7.913M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.8302M |
| Revenue (Quarterly) | 0.0364M |
| Total Expenses (Quarterly) | 0.8666M |
| EPS Diluted (Quarterly) | -0.0017 |
| Gross Profit Margin (Quarterly) | -444.0% |
| Profit Margin (Quarterly) | -2.28K% |
| Earnings Yield | -17.23% |
| Normalized Earnings Yield | -14.36 |